SkinHealth Systems (NASDAQ: SKIN) announced the European launch of its SkinStylus SteriLock MicroSystem, a professional microneedling and nano-needling device for cosmetic use, now available in the UK, Ireland, Germany, France, Spain and Portugal.

The company, which is also home to the Hydrafacial brand, said it will use its existing European commercial organization and provider relationships to distribute SkinStylus to aesthetic professionals in those markets. Availability through select distributor markets is expected to expand beginning in 2027.

SkinHealth Systems acquired SkinStylus in 2023 to broaden its professional skin health portfolio. The device features adjustable settings and multiple SteriLock cartridge options, allowing providers to tailor treatments to individual clients.

Pedro Malha, president and chief executive officer of SkinHealth Systems, said in a statement: "By leveraging the strength of the Hydrafacial device footprint and our established provider relationships, we can bring providers complementary technologies that address a wider range of cosmetic skin concerns and create more opportunities to serve their clients."

Microneedling is a nonsurgical, minimally invasive cosmetic procedure that uses fine needles to create microchannels in the skin, which the company says can help improve the appearance of fine lines, wrinkles and uneven texture.